Key Insights

Highlights

Treatment Research

2 treatments under study, led by The Disposable Pulmonary Radiofrequency Ablation Catheter And Pulmonary Radiofrequency Ablation System

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT06052098Not ApplicableRecruitingPrimary

Transbronchial vs Transthoracic Ablation for Early-stage Peripheral Lung Cancer

Showing all 1 trials

Research Network

Common Treatments

  • The Disposable Pulmonary Radiofrequency Ablation Catheter And Pulmonary Radiofrequency Ablation System1
  • The Disposable Percutaneous Radiofrequency Ablation Needle And Pulmonary Radiofrequency Ablation System1

Active Sponsors

  • Shanghai Chest Hospital1
  • Hangzhou Broncus Medical Co., Ltd.1

Top Investigators

Activity Timeline